SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002643
Filing Date
2020-04-28
Accepted
2020-04-28 16:04:56
Documents
4
Period of Report
2020-06-11
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241466zdef14a.htm DEF 14A 486970
2 G20462BII001.GIF g20462bii001.gif GRAPHIC 102889
3 G20462BII002.GIF g20462bii002.gif GRAPHIC 83056
4 G102608.JPG g102608.jpg GRAPHIC 5386
  Complete submission text file 0001047469-20-002643.txt   751880
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 20824953
SIC: 2834 Pharmaceutical Preparations